期刊文献+

血清脂蛋白相关磷脂酶A2水平与颈动脉内中膜厚度相关性研究 被引量:2

Correlationship study between serum lipoprotein associated phospholipase A2 and carotid intima media thickness
下载PDF
导出
摘要 目的探讨血清脂蛋白相关磷脂酶A2(Lp-PLA2)水平与颈动脉内中膜厚度相关性。方法选取2016年8月至2016年10月我院心内科住院患者179例,常规检测Lp-PLA2水平,并同时测定颈动脉内中膜厚度,以175 ng/mL为临界值分为对照组和Lp-PLA2升高组,分析两组患者的颈动脉内中膜厚度差异性。结果 Lp-PLA2升高组空腹血糖、总胆固醇、甘油三酯、LDL-C及HCY明显高于对照组(P<0.05);Lp-PLA2升高组血清Lp-PLA2水平、双侧颈动脉内中膜厚度明显高于对照组(P<0.01);Lp-PLA2水平与颈动脉内中膜厚度呈正向直线关系(r=0.671,P<0.01);年龄、血压、血糖、总胆固醇、甘油三酯、LDL-C、HCY、LP-PLA2均是影响颈动脉内中膜厚度的独立危险因素(P<0.01);校正传统危险因素后,Lp-PLA2仍是影响颈动脉内中膜厚度的独立危险因素(P<0.01)。结论 Lp-PLA2水平可预测颈动脉内中膜厚度,可作为颈动脉斑块稳定性的预测指标。 Objective To investigate the correlation between serum lipoprotein associated phospholipase A2 (Lp-PLA2) and carotid intima media thickness. Methods One hundred and seventy-nine patients in the department of cardiology of our hospital from August 2016 to October 2016 were selected, and the level of patients" Lp-PLA2 and carotid intima media thickness were detected. With 175 ng/mL Lp-PLA2 as the critical value, they were divided into control group and high Lp-PLA2 level group. The difference of carotid intima media thickness of the two groups were analyzed. Results The levels of fasting blood glucose, total cholesterol, tri^yceride, LDL-C and HCY in the high Lp-PLA2 level group was hisher than those in the control group (P〈O.05); the level of Lp-PLA2 and carotid intima media thickness in the high Lp-PLA2 level group were higher than those in the control group (P〈0.05). There was a positive linear relationship between Lp-PLA2 level and carotid intima media thickness (r=0.671,P〈0.01). The age, blood pressure, blood glucose, and the levels of total cholesterol, triglyceride, LDL-C, plasma homocysteine and LP-PLA2 were independent risk factors of carotid intima media thickness (P〈0.01); after adjusting traditional risk factors, Lp-PLA2 was also an independent risk factor the carotid intima media thickness (P〈0.01). Conclusion Carotid artery intima media thickness can be predicted by Lp-PLA2, which can be used as a marker for predicting the stability of carotid plaque.
作者 马涛 李小军 杨瑞金 白玲强 耿倩雯 MA Tao LI Xiao-jun YANG Rui-jin BAI Ling-qiang GENG Qian-wen(the Third Hospital of Military, Baoji 721001, China)
机构地区 解放军第三医院
出处 《临床医学研究与实践》 2017年第13期8-10,共3页 Clinical Research and Practice
关键词 脂蛋白相关磷脂酶A2 颈动脉内中膜厚度 相关性 lipoprotein-associated phospholipase A2 the carotid intima media thickness correlation
  • 相关文献

参考文献2

二级参考文献27

  • 1刘甲兴,郑兴,秦永文,丁继军,赵仙先,曹江.脂蛋白相关性磷脂酶A_2活性能反映冠状动脉粥样硬化病变程度[J].第二军医大学学报,2006,27(4):391-395. 被引量:31
  • 2中华医学会神经科学会.各类脑血管疾病诊断要点及临床功能缺损程度评分标准(1995).中华神经科杂志,1996,29:379-379.
  • 3Kolodgie FD, Burke AP, Skorija KS, et al. Lipoprotein-associ- ated phospholipaseA2 protein expression in the natural progres- sion of human coronary atherosclerosis [J]. Arterioscler Thromb Vasc Biol, 2006, 26 (11): 2523-2529.
  • 4Jang Y, Kin OY, Koh SJ, et al. The Val279Phe variant of the lipoprotein-associated phospholipaseA2 gene is associated with catalytic activities and cardiovascular disease in Korean men [J]. J Clin Endocrinol Metab, 2006, 91 (9): 3521 -3527.
  • 5Koenig W, Twardella D, Brenner H, et al. Lipoprotein -asso- ciated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflaramation, renal function, and he modynamic stress [J]. Arterioscler Thromb Vasc Biol, 2006, 26 (7): 1586-1593.
  • 6Sutton BS, Crosslin DR, Shah SH, et al. Comprehensive genetic a- nalysis of the platelet activating factor acetylhydrolase (PLA2GT) gene and cardiovascular disease in case-control and family datasets [J]. Hum Mol Genet, 2008,17(9) : 1318- 1328.
  • 7Hou L, Chen, S, Yu H, et al. Associations of PLA2G7 gene polymorphisms with plasma lipoprotein- associated phospho- lipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study [J]. Hum Genet, 2009, 125 (1): 11-20.
  • 8Ninio E, Tregouet D, Carrier JL, et al. PAF-AH and PAF- receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease [J]. Hum Mol Genet, 2004, 13 (13): 1341-1351.
  • 9Liu PY, Chung HC, Chen JY, et al. Platelet-activating factor -acetylhydrolase (PLA2GT) A379V (Exon 11) gene polymor- phism is functionally associated with coronary artery disease se- verity but not onset of acute coronary syndrome [J]. Acta Car- diolSin, 2006, 22: 212-220.
  • 10Kokubo Y, Tomoike H, Tanaka C, et al. Association of sixty- one non-synonymous polymorphisms in forty-one hypertension candidate genes with blood pressure variation and hypertension [J]. Hypertens Res, 2006, 29 (8): 611-619.

共引文献30

同被引文献21

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部